Meriolin 6

Meriolin 6

SCHEMBL2999009

CC(C)Oc1ccnc2[nH]cc(-c3ccnc(N)n3)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 15/20 1.00
CDK5R1 Q15078 15/20 1.00
CCNT1 O60563 13/20 1.00
CDK9 P50750 13/20 1.00
CDK2 P24941 13/20 1.00
CCNA2 P20248 12/20 1.00
CCNA1 P78396 11/20 1.00
PDPK1 O15530 2/20 0.52
HTR1A P08908 2/20 0.52
HTR2B P41595 2/20 0.52
HTR7 P34969 1/20 0.52
HTR5A P47898 1/20 0.52
GSK3B P49841 6/20 0.46
DYRK1A Q13627 4/20 0.46
NFATC1 O95644 2/20 0.46
CCNB2 O95067 2/20 0.46
CDK1 P06493 2/20 0.46
CCNB1 P14635 2/20 0.46
PRKACA P17612 2/20 0.46
PRKACG P22612 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Meriolin 6 SCHEMBL31061569 1.00 CDK5 (1.00) CDK5CDK5R1CCNT1CDK9CDK2
SCHEMBL2995218 0.88 CDK5 (0.79) CDK5CDK5R1CCNT1CDK9CDK2
SCHEMBL2998398 0.87 CDK5 (0.77) CDK5CDK5R1CCNT1CDK9CDK2
Meriolin 3 SCHEMBL29489951 0.86 CCNT1 (1.00) CDK5CDK5R1CCNT1CDK9CDK2
Meriolin 3 SCHEMBL2996575 0.86 CCNT1 (1.00) CDK5CDK5R1CCNT1CDK9CDK2
SCHEMBL12347468 0.85 CDK5 (0.74) CDK5CDK5R1CCNT1CDK9CDK2
Meriolin 4 SCHEMBL3001373 0.84 CDK5 (1.00) CDK5CDK5R1CCNT1CDK9CDK2
Meriolin 4 SCHEMBL31061625 0.84 CDK5 (1.00) CDK5CDK5R1CCNT1CDK9CDK2
SCHEMBL2998751 0.82 CDK5 (0.75) CDK5CDK5R1CCNT1CDK9CDK2
Meriolin 5 SCHEMBL2997013 0.81 CDK5 (1.00) CDK5CDK5R1CCNT1CDK9CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125803-B1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF CENTRE NAT RECH SCIENT (FR) 2013-04-10 EP claimed
US-20100184790-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-07-22 US claimed
EP-2125803-B1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF CENTRE NAT RECH SCIENT (FR) 2013-04-10 EP disclosed
US-20100184790-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-07-22 US disclosed
US-20100184790-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-07-22 US disclosed
WO-2010003133-A2 CDK MODULATORS EXELIXIS INC. (US) 2010-01-07 WO disclosed
WO-2008129152-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184790-A1 PYRROLO[2,3-B]PYRIDINE COMPOUNDS, AZAINDOLE COMPOUNDS USED FOR SYNTHESIZING SAID PYRROLO[2,3-B]PYRIDINE COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, AND USES THEREOF BAD, PPOX, CASP3 CDK5 15/4885CDK5R1 64/4885CCNT1 1121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.